Skip to main content

Day: May 18, 2022

Form 8.3 – [SECURE INCOME REIT PLC – 17 05 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SECURE INCOME REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LXI REIT PLC – 17 05 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXI REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [IDEAGEN PLC – 17 05 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Life Clips Reports Fiscal 2022 Third Quarter and Nine Month Results

Belfrics Group revenues increased 32.6 percent in the third quarter to $2.96 million from $2.235 million Total revenues for the first nine months of fiscal 2022 are $5.24 millionAVENTURA, Fla., May 18, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today reported financial results from its Belfrics Group subsidiary for the third quarter of fiscal 2022, ended March 31, 2022. Total revenues from Belfrics Group in the third quarter of fiscal 2022 were $2.96 million, an increase of 32.6 percent compared to $2.235 million in the previous quarter, and a 100% increase from the prior year quarter. Commissions and Fees increased 29 percent to $2.04 million in the third quarter of fiscal 2022 as compared to $1.58 million in the previous quarter. Investment Advisory revenue increased 84 percent to $662,478 in...

Continue reading

Ideal Power to Present at H.C. Wainwright Global Investment Conference

AUSTIN, Texas, May 18, 2022 (GLOBE NEWSWIRE) — Ideal Power Inc. (Nasdaq: IPWR), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN™ bidirectional semiconductor power switch, today announced its participation in the H.C. Wainwright Global Investment Conference. Dan Brdar, President and Chief Executive Officer, and Tim Burns, Chief Financial Officer, are scheduled to present and hold meetings with investors as follows: H.C. Wainwright Global Investment ConferencePresentation Date/Time: Virtual presentation will be available starting at 7:00 a.m. ET on Tuesday, May 24, 2022 Webcast: https://journey.ct.events/view/c7f6a0a5-f011-4b3b-ac0e-13f2b8f12bed Meeting availability: May 24th-26th A webcast replay of the presentation session and a copy of Ideal Power’s latest investor presentation...

Continue reading

Verizon to speak at MoffettNathanson Summit May 19

NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) — Tami Erwin, executive vice president for Verizon (NYSE, Nasdaq: VZ), and CEO for Verizon Business, is scheduled to speak at the ninth annual MoffettNathanson Media & Communications Summit on Thursday, May 19, at 9:00 a.m. ET. Her remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors. Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is one of the world’s leading providers of technology and communications services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $133.6 billion in 2021. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for...

Continue reading

AVEO Oncology Announces Participation at the H.C. Wainwright Global Investment Conference

BOSTON, May 18, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 1:30 p.m. eastern time. A live webcast of the fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 30 days following the presentation date. About AVEO Pharmaceuticals, Inc. AVEO is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients...

Continue reading

Golden Triangle Ventures, Inc. Announces Binding LOI to Acquire all Assets and Intellectual Property from Le Pragma, LLC and Provides Additional Corporate Developments

LAS VEGAS, May 18, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is pleased to announce that after nearly 10 months of work it has executed a Binding Letter of Intent (“LOI”) and has formalized the complete terms to acquire all assets and intellectual property of Le Pragma, LLC, a full retail line of high-end, all-natural, health, wellness and beauty products. Created by the founders of Sonder Fulfillment, Le Pragma was designed from conception to have a universal appeal as a luxurious cannabinoid brand distributed throughout the world. With a strategic vision of going beyond products and introducing an everyday use regimen that compliments an active lifestyle, Le Pragma seeks to become the “CBD line of the future.” Additionally, Le Pragma’s cutting-edge...

Continue reading

Strong Adoption of Xactly’s Intelligent Revenue Platform Drives Growth in Q1

Increased Focus on Profitability Fuels Demand as Customers Seek Intelligent Revenue Solutions SAN JOSE, Calif., May 18, 2022 (GLOBE NEWSWIRE) — Xactly, the leader in intelligent revenue solutions, announced a rapid increase in adoption of its Intelligent Revenue Platform (IRP), fueling strong growth in the first quarter. Half of the company’s largest deals were driven by customers expanding beyond traditional Incentive Compensation Management (ICM) and Sales Performance Management (SPM) solutions. “As continued global market uncertainty unfolds, our customers are turning to our Intelligent Revenue Platform to help them maintain momentum while protecting profit margins,” said Bernie Kassar, Chief Customer Officer of Xactly. “With customer outcomes in mind, we’ve invested in building a platform that supports business resilience –...

Continue reading

SANUWAVE Business Update

Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month  First Quarter Revenue of $3.2 Million an Increase of 100% Year Over Year SUWANEE, GA, May 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – On May 17, 2022, SANUWAVE Health, Inc. (OTC:PINK: SNWV), a leading provider of next-generation wound care products, announced they successfully filed their 10-K for 2021 and provided an update on April Sales Funnel and System Trials. The company also filed an NT10Q for their first quarter filing.  In the NT10Q they released preliminary revenue for the first quarter of 2022.  This release provides further color on that SEC filing. Both the Sales Funnel, defined as opportunities the direct sales team is pursuing to close in the next six months, and System Trials, defined as single 60-day assessments underway for evaluating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.